Catawba Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $307K | Hold |
3,260
| – | – | 0.07% | 168 |
|
|
2018
Q1 | $264K | Sell |
3,260
-40
| -1% | -$3.24K | 0.06% | 180 |
|
|
2017
Q4 | $294K | Sell |
3,300
-670
| -17% | -$59.7K | 0.07% | 175 |
|
|
2017
Q3 | $369K | Sell |
3,970
-345
| -8% | -$32.1K | 0.08% | 167 |
|
|
2017
Q2 | $392K | Buy |
4,315
+160
| +4% | +$14.5K | 0.09% | 164 |
|
|
2017
Q1 | $365K | Hold |
4,155
| – | – | 0.08% | 186 |
|
|
2016
Q4 | $344K | Buy |
4,155
+715
| +21% | +$59.2K | 0.08% | 184 |
|
|
2016
Q3 | $318K | Buy |
+3,440
| New | +$318K | 0.08% | 186 |
|
|
2015
Q3 | – | Sell |
-2,040
| Closed | -$279K | – | 239 |
|
|
2015
Q2 | $279K | Hold |
2,040
| – | – | 0.07% | 201 |
|
|
2015
Q1 | $254K | Sell |
2,040
-185
| -8% | -$23K | 0.06% | 217 |
|
|
2014
Q4 | $201K | Buy |
+2,225
| New | +$201K | 0.05% | 238 |
|